Literature DB >> 9779844

Silica induced scleroderma--clinical and experimental aspects.

U F Haustein1, U Anderegg.   

Abstract

Clinical and experimental data concerning silica induced systemic sclerosis (SSc) are discussed in comparison to current knowledge of the pathophysiology of idiopathic SSc. About 280 patients with SSc after longterm silica dust exposure, some with associated silicosis, have been reported; 111 of them were analyzed as the largest cohort in our department. Based on clinical and laboratory data, silica induced and idiopathic SSc show similar pathophysiology and similar markers of the disease including vascular involvement, immunological abnormalities, and dysregulation of extracellular matrix metabolism. Experimental studies show that silica dust is able to activate microvascular endothelial cells, mononuclear cells from peripheral blood, and dermal fibroblasts in vitro in a fashion in common with pathophysiological events known from idiopathic SSc.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9779844

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  19 in total

1.  Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients.

Authors:  T Otsuki; A Tomokuni; H Sakaguchi; T Aikoh; T Matsuki; Y Isozaki; F Hyodoh; H Ueki; M Kusaka; S Kita; A Ueki
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Connective tissue diseases after heavy exposure to silica: a report of nine cases in stonemasons.

Authors:  Samy Slimani; Amina Ben Ammar; Aicha Ladjouze-Rezig
Journal:  Clin Rheumatol       Date:  2010-01-28       Impact factor: 2.980

3.  Detection of anti-topoisomerase I autoantibody in patients with silicosis.

Authors:  Akiko Tomokuni; Takemi Otsuki; Haruko Sakaguchi; Yumika Isozaki; Fuminori Hyodoh; Masayasu Kusaka; Ayako Ueki
Journal:  Environ Health Prev Med       Date:  2002-04       Impact factor: 3.674

4.  Association of pulmonary silicosis and systemic sclerosis.

Authors:  Kaouther Ben Abdelghani; Alia Fazaa; Leila Souabni; Leith Zakraoui
Journal:  BMJ Case Rep       Date:  2015-01-27

5.  Alteration of fibroblast phenotype by asbestos-induced autoantibodies.

Authors:  Jean C Pfau; Sheng'ai Li; Sara Holland; Jami J Sentissi
Journal:  J Immunotoxicol       Date:  2011-04-04       Impact factor: 3.000

Review 6.  Silica exposure and altered regulation of autoimmunity.

Authors:  Suni Lee; Hidenori Matsuzaki; Naoko Kumagai-Takei; Kei Yoshitome; Megumi Maeda; Ying Chen; Masayasu Kusaka; Kozo Urakami; Hiroaki Hayashi; Wataru Fujimoto; Yasumitsu Nishimura; Takemi Otsuki
Journal:  Environ Health Prev Med       Date:  2014-08-19       Impact factor: 3.674

7.  Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis.

Authors:  Rajpreet K Arora-Singh; Shervin Assassi; Deborah J del Junco; Frank C Arnett; Marilyn Perry; Uzma Irfan; Roozbeh Sharif; Tony Mattar; Maureen D Mayes
Journal:  J Autoimmun       Date:  2010-03-11       Impact factor: 7.094

8.  A case of localized scleroderma in a sculptor and his wife.

Authors:  Richard Bakst; Carrie Kovarik; Victoria P Werth
Journal:  J Clin Rheumatol       Date:  2009-12       Impact factor: 3.517

9.  [Medico-legal assessment of systemic sclerosis].

Authors:  M Graninger
Journal:  Z Rheumatol       Date:  2007-10       Impact factor: 1.372

10.  Occupational silica exposure as a risk factor for scleroderma: a meta-analysis.

Authors:  Zachary D McCormic; Sura S Khuder; Bishwa K Aryal; April L Ames; Sadik A Khuder
Journal:  Int Arch Occup Environ Health       Date:  2010-01-03       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.